Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Completed 9Unknown 8Recruiting 3Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 4Gastrointestinal 3Gynecologic 2Genitourinary 1CNS 1Breast 1

Conditions

Ovarian Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Oxaliplatin 197Bevacizumab 162Fluorouracil 154Capecitabine 137Gemcitabine 135Leucovorin 110pembrolizumab 99Cisplatin 95Drug Therapy 89Irinotecan 79Radiotherapy 73sintilimab 70130-nm albumin-bound paclitaxel 67durvalumab 66Paclitaxel 65Specimen Handling 63Cetuximab 63lenvatinib 59tislelizumab 58Magnetic Resonance Spectroscopy 56Nivolumab 55Folfox protocol 55Blood Specimen Collection 52Biopsy 47atezolizumab 46Taxes 40Surgical Procedures, Operative 40Albumin-Bound Paclitaxel 39Immune Checkpoint Inhibitors 37HMPL-013 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Propofol × Gastrointestinal × Clear all
NCT04513808 2024-12-04

Total Intravenous Anesthesia and Recurrence Free Survival

The Cleveland Clinic

Phase 3 Recruiting
1,614 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT05926336 2023-09-28

The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action

Kaohsiung Medical University Chung-Ho Memorial Hospital

Phase 4 Recruiting
1,316 enrolled
CNSGastrointestinalGynecologicThoracic

Brain Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms

NCT05331911 2022-11-30

Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors

Kaohsiung Medical University Chung-Ho Memorial Hospital

Phase 4 Recruiting
500 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡